The analysis included patients who were referred to the Department of Gastroenterology, Hepatology and Infectious Diseases, to the Department of Surgery or to the Department of Radiology and ...

An expert discusses how, for advanced unresectable hepatocellular carcinoma (uHCC), clinicians monitor treatment efficacy ...

Discover how Yttrium-90 radioembolisation may offer improved survival for large hepatocellular carcinoma tumours compared to ...

Direct-acting antivirals (DAAs) have dramatically changed the landscape of chronic hepatitis C virus (HCV) treatment and ...

Liver cancer, predominantly hepatocellular carcinoma (HCC), remains one of the most aggressive and leading causes of ...

Hepatocellular carcinoma (HCC) represents a significant ... Recent advancements in liver imaging, particularly the use of hepatocyte-specific contrast agents, have enhanced the detection of ...

Panelists discuss how emerging evidence suggests that combining transarterial chemoembolization (TACE) with systemic therapy ...

Table 3. Racial demographics of hepatocellular carcinoma cases (n = 48,596) in the USA, 2001–2006. Race Average annual number of cases Incidence rate over entire period Average annual % change ...

A research team led by Prof. SUN Cheng from the University of Science and Technology of China (USTC) of the Chinese Academy of Sciences, along with collaborators from the Agency for Science, ...

This is called secondary liver cancer or liver metastases. Hepatocellular carcinoma is also called hepatoma or HCC. It's the most common type of primary liver cancer. Because of this, the information ...